Mkts

Seres Therapeutics, Inc.

NASDAQ: MCRB
$2.09-0.04 (-1.88%)
As of Oct 23, 4:00 PM ET

Key statistics

Day range
2.002.17
52-week range
2.0029.98
Today
Open2.13
Previous close2.09
Volume71.2K
Valuation
Market cap20.78M
P/E ratio—
EPS (TTM)-2.33
Income & risk
Dividend / yield—
Beta0.53
Avg volume80.4K
Discussion

MCRB News

Stories mentioning MCRB from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue358.00351.000.000.000.000.00
Cost of Goods Sold
Gross Profit0.00
Operating Expenses
Research & Development13,19511,68412,61612,93911,82112,84016,46015,806
Sales General & Admin
Total Operating Expenses21,26519,81522,82824,88127,23628,83629,17028,871
Operating Income (Loss)(20,907)(19,377)(22,477)(24,881)(27,236)(28,836)(29,170)(28,871)
Interest Income325.00445.00618.00546.00618.00437.00652.001,230
Interest Expense
Other Expense669.002,5002,8414,2957,1196,460(22,517)1,445
Pretax Income
Tax Provision0.000.000.000.000.000.000.000.00
Net Income (Loss)(19,913)(15,335)8,204(19,855)32,682(15,637)88,776(32,870)
Earnings Per Share (Basic)(2.08)(1.73)0.94(2.27)3.76(2.01)11.63(4.34)
Earnings Per Share (Diluted)(2.08)(1.73)0.94(2.27)3.75(2.01)11.63(4.34)
Weighted Average Shares Outstanding (Basic)9,5838,8598,7598,7448,7037,7707,6327,576
Weighted Average Shares Outstanding (Diluted)9,5838,8708,7728,7448,7157,7707,6327,576

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About MCRB

Seres Therapeutics, Inc. (NASDAQ: MCRB) is a stock listed on the Nasdaq Stock Market under the ticker symbol MCRB. It last traded at $2.09 (Oct 23, 2026, 4:00 PM ET), down 1.9% on the day. That gives Seres Therapeutics a market capitalisation of $20.8M.

Over the past 52 weeks MCRB has traded between $2.00 and $29.98.

Revenue for the quarter ended Mar 31, 2026 was $358.0K; a net loss of $19.9M.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$358.0K-$19.9M-5562.3%
Dec 31, 2025—-$15.3M—
Sep 30, 2025$351.0K$8.2M2337.3%
Jun 30, 2025—-$19.9M—

From Seres Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…